Company Name

Industry

Location

Revenue

Employees

Azzur Group

Pharmaceuticals

United States, Pennsylvania

$100M to $250M

201-500

ZO Skin Health

Pharmaceuticals

United States, California

$100M to $250M

201-500

BioPlus Specialty Pharmacy

Pharmaceuticals

United States, Florida

$100M to $250M

201-500

Hyde Engineering + Consulting

Pharmaceuticals

United States, Colorado

$100M to $250M

201-500

Lifecore Biomedical

Pharmaceuticals

United States, Minnesota

$100M to $250M

201-500

Dicerna Pharmaceuticals

Pharmaceuticals

United States, Massachusetts

$100M to $250M

201-500

Oyster Point Pharma

Pharmaceuticals

United States, New Jersey

$100M to $250M

201-500

UPM Pharmaceuticals

Pharmaceuticals

United States, Tennessee

$100M to $250M

201-500

Avid Bioservices

Pharmaceuticals

United States, California

$100M to $250M

201-500

Noven Pharmaceuticals

Pharmaceuticals

United States, Florida

$100M to $250M

201-500

Clinical ink

Pharmaceuticals

United States, North Carolina

$100M to $250M

201-500

Radius Health

Pharmaceuticals

United States, Massachusetts

$100M to $250M

201-500

Karyopharm Therapeutics

Pharmaceuticals

United States, Massachusetts

$100M to $250M

201-500

Catalyst Clinical Research

Pharmaceuticals

United States, North Carolina

$100M to $250M

201-500

PerformRx

Pharmaceuticals

United States, Pennsylvania

$100M to $250M

201-500

NorthStar Medical Radioisotopes

Pharmaceuticals

United States, Wisconsin

$100M to $250M

201-500

Recordati Rare Diseases North America

Pharmaceuticals

United States, New Jersey

$100M to $250M

201-500

Zogenix

Pharmaceuticals

United States, California

$100M to $250M

201-500

Norwich Pharma Services

Pharmaceuticals

United States, New York

$100M to $250M

201-500

Athenex

Pharmaceuticals

United States, New York

$100M to $250M

201-500